News

Dozens of lawmakers are urging U.S. health regulators to crack down on the booming market for knockoff weight-loss drugs amid ...
Experts say supplement companies have tried to capitalize on the GLP-1 craze, putting the phrase in their product names, ...
Companies are selling personalized compounded drugs that combine weight loss and erectile dysfunction treatments, but is this ...
Powerful new medications such as Ozempic and Mounjaro, known as GLP-1 drugs are helping to win the war against obesity in ...
The U.S. Food and Drug Administration has approved PTC Therapeutics' oral drug to treat a rare inherited metabolic disorder ...
UnitedHealth Group's pharmacy benefits manager, OptumRx Inc., was hit with an Employee Retirement Income Security Act of 1974 ...
Wegovy is FDA-approved for weight loss in people with a BMI of 30 or more or 27 or higher with at least one weight-related health condition. Some insurance plans do cover it, though coverage varies.
GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...
In a repeated attempt to eliminate the only FDA approved class of weight loss drugs, Public Citizen issued a second petition to the U.S. Food and Drug Administration Thursday calling for the ...
The Food and Drug Administration on Friday approved Eli Lilly 's blockbuster weight loss drug Zepbound for treating patients with the most common sleep-related breathing disorder, expanding its ...
Belviq is one of three experimental weight-loss drugs whose developers have been trying for a second time to win approval, after the FDA shot them all down in 2010 or early 2011 because of serious ...